News & Intelligence
Caribbean health intelligence, FDA alerts, vendor news, and industry trends — updated daily from 130+ sources.
PAHO Barbados: Norovirus Cluster Detected in Cruise Ship Passengers
Norovirus gastroenteritis cluster reported among cruise passengers disembarking in Barbados. Port health screening enhanced.
New Hardy Colilert-18 Water Testing Protocol Reduces Turnaround Time
Hardy Diagnostics has validated a new 18-hour Colilert protocol for Caribbean water utilities, reducing standard 24-hour testing by 25%.
CARPHA Issues Dengue Surveillance Advisory for Eastern Caribbean
CARPHA has issued an updated epidemiological advisory noting increased dengue activity across the Eastern Caribbean, with elevated case counts in Barbados, Saint Lucia, and Trinidad and Tobago. Laboratories are advised to ensure adequate stock of NS1 antigen and IgM/IgG rapid test kits.
Horiba Medical Releases Yumizen H-Series Firmware Update v3.2
Horiba Medical has released firmware version 3.2 for the Yumizen H500 and H550 hematology analyzers, featuring improved flagging algorithms for platelet clumps and enhanced connectivity with laboratory information systems.
Caribbean Laboratories Increasingly Adopting Molecular Diagnostics
A growing number of Caribbean laboratories are investing in molecular diagnostic platforms, driven by lessons learned during COVID-19 and the need for rapid, accurate pathogen identification for dengue, chikungunya, and Zika.
Seasonal Influenza Uptick Noted in Bahamas and Jamaica
Public health authorities in The Bahamas and Jamaica have reported an early-season increase in influenza A (H3N2) cases, with hospital admissions rising 22% over baseline in the past two weeks. Laboratories are advised to ensure adequate influenza rapid test and RT-PCR reagent supplies.
ZOLL AED 3 Now Available with WiFi Fleet Management
ZOLL Medical has launched the AED 3 with integrated WiFi connectivity, enabling automated self-testing, real-time readiness monitoring, and centralized fleet management. Ideal for hotels, airports, and government buildings across the Caribbean.
FDA Issues Class II Recall for Competitor HbA1c Analyzer
The FDA has issued a Class II recall affecting the Afinion HbA1c analyzer due to potential inaccurate glucose measurements. Caribbean labs using this system should verify their results. The Tosoh G8 and GR-01 analyzers from Caribbean Diagnostics remain unaffected and offer NGSP-certified accuracy.
Stay informed
Get Caribbean health intelligence delivered to your inbox. FDA alerts, outbreak monitoring, vendor updates, and product launches.